16 December 2024

UK Researchers Awarded £6.4M Grant to Study Protein Dynamics and Cell Health

04 December 2024

Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs

07 November 2024

Exploring Molecular Glues: Insights from the Sir Geoffrey Wilkinson Lecture

19 September 2024

Institute for Molecular Science and Engineering (IMSE) Research Showcase 2024

01 August 2024

New tool could transform study of cells and help find new drug targets

08 July 2024

Imperial and Crick cancer drug spinout raises £90m to begin clinical development

13 June 2024

Mathematics PhD student wins major science communication competition

01 April 2024

New synthesis platform allows for rapid cancer drug synthesis and testing

26 March 2024

Eight things we learned about commercialising medical research at AYCI 2024

07 March 2024

Impact of artificial intelligence on AMR: Common themes and challenges

11 January 2024

New class of cancer and immunology drug targets mapped with new tagging system

27 November 2023

Unraveling the Secrets of Zombie cells

16 November 2023

UK approves world-first gene-editing treatment for blood disorders

31 October 2023

New £28m Centre to forge the next generation of AI digital healthcare innovators

20 October 2023

Towards using quantum computing to speed up drug development

19 October 2023

New mechanism found that maintains water balance within cells

13 October 2023

Imperial President - College making big moves to accelerate medical innovation

06 September 2023

Apollo Therapeutics raises $226.5m to develop medicines based on uni research

21 August 2023

Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial

20 July 2023

New database of drug targets will help fight incurable diseases

23 May 2023

Imperial and Agilent renew partnership for flagship analytical science facility

22 May 2023

New partnership will use molecular glues to tackle ‘undruggable’ disease targets

21 February 2023

Research shows how human cells are protected when the immune system switches on

20 February 2023

UV-light activated probe finds new interactions in living cells

14 February 2023

Professor Ed Tate appointed to the GSK Chair in Chemical Biology

22 January 2023

Wearable tech, AI and clinical teams join to change the face of trial monitoring

16 December 2022

Innovation and entrepreneurship at Imperial: A year in review

02 November 2022

CRISPR-based oligo recombineering in drug discovery

21 October 2022

Observing the early universe and supporting net-zero: News from the College

20 September 2022

Epigenetic treatment in mice improves spinal cord regeneration after injury

17 August 2022

Imperial startup GlioQuell has the power to shut down cancer cells

01 July 2022

New device could accelerate the development of T-cell immunotherapies for cancer

27 June 2022

Intermittent fasting may help heal nerve damage

18 February 2022

New treatment could boost radiotherapy effectiveness for brain tumour patients

18 February 2022

AI for life sciences research gets boost from the financial markets

01 February 2022

Identification of the first covalent ligands of the small GTPase Rab27A